Platelet Activity and Blood Lipid Changes in Diabetes Mellitus

  • F. Riolo
  • G. Davì
  • S. Novo
  • A. Pinto
  • G. Mendola
  • G. Avellone
  • M. Russotto
  • A. Strano
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 164)


An altered platelet function can often be found in diabetes mellitus (2, 3, 4, 10, 13, 16, 17, 23, 24). Several studies have pointed towards an increased sensitivity of platelets to ADP induced aggregation (3, 6, 23) in diabetic patients; this phenomenon can also be found in diabetics without apparent vasculopathy and in subjects with altered glucose tolerance (3, 23).


Diabetic Patient Diabetic Retinopathy Prostaglandin Endoperoxide Malondialdehyde Production Thrombin Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H.P. Chase, R.L. Williams, S. Dupont, Increased prostaglandin synthesis in chilhood diabetes mellitus. J. Pediatr. 94: 185 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    B.S. Coller, R.N. Frank, R.C. Milton, H.R. Gralnick, Plasma cofactors of platelet function: correlation with diabetic retinopathy and haemoglobin A1a-C. Ann. Int. Med. 58:311 (1978).Google Scholar
  3. 3.
    J.A. Colwell, J. Sagel, R. Pennington, M. Meeks, R. Scarpatto, M. Laiminis, Effect of therapy on platelet aggregation in diabetes. Clin. Res. 21:884 (1973).Google Scholar
  4. 4.
    J.A. Colwell, P.V. Halushka, Platelet function in diabetes mellitus. Brit. J. Haemat. 44:521 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    U. Diczfalusy, P. Falarderan, S. Hammarstrom, Conversion of prostaglandin endoperoxides to C1hydroxy acids catalyzed by human platelet thromboxane synthase. Fed. Eu. Biochem. Soc. Let. 82:271 (1977).CrossRefGoogle Scholar
  6. 6.
    A.I. Fleischman, M.L. Bierembaum, A. Stier, In vivo platelet function in diabetes mellitus. Thromb. Res. 8:467 (1976).CrossRefGoogle Scholar
  7. 7.
    S.K. Garg, H. Lockner, S. Karpatkin, The increased percentage of magathrombocytes in various clinical disorders. Ann. Int.Med. 77:361 (1972).PubMedGoogle Scholar
  8. 8.
    P.V. Halushka, D. Lurie, J.A. Colwell, Increased synthesis of prostaglandin-E-like material by platelet from patients with diabetes mellitus. N. Engl. J. Med. 297:1406 (1977).CrossRefGoogle Scholar
  9. 9.
    P.V. Halushka, J.A. Colwell, C. Rogers, C.D. Loudbalt, B. Gartner, Increased thromboxane (TxB2) synthesis by platelets from patients with diabetes mellitus: studies with a Tx-synthetase inhibitor and Tx-receptor antagonist. Clin. Res. 27:296 (1979).Google Scholar
  10. 10.
    H. Heath, W.D. Bridgen, J.V. Canever, Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7:308 (1971).PubMedCrossRefGoogle Scholar
  11. 11.
    A.J. Hellem, Adenosindiphosphate induced platelet adhesiveness in diabetes mellitus with complication. Acta Med. Scand. 190:291 (1971).PubMedCrossRefGoogle Scholar
  12. 12.
    D.J. Horns, J.M. Gerrard, G.H. Rao, W. Krivit; J.G. White, Smoking and platelet liable aggregation stimulating substances (LASS) synthetizing activity. Thromb. Res. 9: 661 (1967).CrossRefGoogle Scholar
  13. 13.
    E.A. Jaffe, Endothelial cells and biology of factor VIII. New Engl. J. Med. 296:377 (1977).PubMedCrossRefGoogle Scholar
  14. 14.
    S. Karpatkin, Haeterogenity of human platelets II. Evidence of young and old platelets. Clin. Invest. 48:1083 (1969).CrossRefGoogle Scholar
  15. 15.
    M. Lagarde, M. Dechavanne, Increase of platelet prostaglandin cyclic endoperoxides in thrombosis. Lancet 1:88 (1977).PubMedCrossRefGoogle Scholar
  16. 16.
    E. Lufkin, D.N. Fass, W.M. O’Fallion, E.J.W. Bowie, Increased von Willebrand factor in diabetes mellitus. Metabolism 28: 63 (1979).PubMedCrossRefGoogle Scholar
  17. 17.
    M. Murray, M.D. Burn, Platelet function in diabetes mellitus. Diabetes 27:342 (1978).Google Scholar
  18. 18.
    G.G. Neri Serneri, G.F. Gensini, R. Abbate, Some aspects of the change of the haemostatic system in diabetes mellitus. In: Atti del Congresso “Giornate Internazionali di Diabetologia”. Roma, 17–19 Novembre 1977, p. 133.Google Scholar
  19. 19.
    G.G. Neri Serneri, La sindrome trombofilica nella malattia diabetica. In: Atti 80° Congresso Società Italiana di Medicina Interna, 552, (1979).Google Scholar
  20. 20.
    A. Nordoy, J.M. Rodset, Platelet phospholipids and their function in patients with juvenile diabetes and maturityonset diabetes. Diabetes 19:698 (1970).PubMedGoogle Scholar
  21. 21.
    M. Okuma, M. Steiner, G.M. Baldin, Studies on lipid peroxides in platelets II. Effects of aggregation agents and platelet antibody. J. Lab. Clin. Med. 77:728 (1971).PubMedGoogle Scholar
  22. 22.
    F.E. Preston, J.D. Ward, B.H. Marcola, N.R. Porter, W.R. Timperley, Elevated betathromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1: 238 (1978).PubMedCrossRefGoogle Scholar
  23. 23.
    J. Sagel, J.A. Colwell, L. Crook, M. Laminis, Increased platelet aggregation in early diabetes mellitus. Ann Int. Med. 82:733 (1972).Google Scholar
  24. 24.
    H.N. Seth, Fibrinolytic response to moderate exercise and platelet adhesiveness in diabetes mellitus. Acta Diabet. Lat. 10:306 (1973).CrossRefGoogle Scholar
  25. 25.
    M.J. Stuart, H. Erald, J.E. Graeber, D.O. Hakanson, M.K. Barvinchank, Increased synthesis of prostaglandin endoperoxides and platelets hyperfunction in infants of mother with diabetes mellitus. J. Lab. Clin. Med. 94:12 (1979).PubMedGoogle Scholar
  26. 26.
    M.J. Stuart, S. Murphy, F.A. Oski, A simple non radioisotope technic for the determination of platelet life-span. New Engl. J. Med. 292:1310 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    M.J. Stuart, J.M. Gerrad, J.G. White, Effect of cholesterol on production of thromnoxane B2 by platelets in vitro. New Engl. J. Med. 302:6 1980.PubMedCrossRefGoogle Scholar
  28. 28.
    E. Tremoli, P. Maderna, CR. Sirtori, Platelet aggregation and malondialdehyde formation in type IIa hypercholesterolemic patients. Haemostasis 8:47 (1979).PubMedGoogle Scholar
  29. 29.
    J. Viikari, Precipitation of plasma lipoproteins by PEG-6000. Scand. J. Clin. Invest. 36:265 (1976).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • F. Riolo
    • 1
  • G. Davì
    • 1
  • S. Novo
    • 1
  • A. Pinto
    • 1
  • G. Mendola
    • 1
  • G. Avellone
    • 1
  • M. Russotto
    • 1
  • A. Strano
    • 1
  1. 1.Institute of Clinical Medicine and Medical TherapyUniversity of PalermoPalermoItaly

Personalised recommendations